PhotoMedex, Inc., is a medical device and specialty pharmaceutical company. The Company operates in four business units: three in Dermatology and one in Surgical. The Domestic XTRAC segment derives revenues from procedures performed by dermatologists in the United States. The Company's XTRAC system is placed in a dermatologist's office without any initial capital cost and then the Company charges a fee-per-use to treat skin disease. The International Dermatology segment, generates revenues from the sale of equipment and replacement parts to dermatologists outside the United States through a network of distributors. The Surgical products segment generates revenues by selling laser products and disposables to hospitals, surgery centers and doctors both domestically and internationally. In March 2009, the Company announced the closing of the acquisition of Photo Therapeutics Limited.